PTC Therapeutics

PTC logo

PTC Therapeutics is a global biopharmaceutical company focused on the discovery, development and commercialization of orally administered, proprietary small molecule drugs targeting an area of RNA biology they refer to as post-transcription control.

Research focus: Stop Codon Readthrough.

Status:  Clinical.  Conditional approval in the EU.


Related Posts

Share This Page

Make an Impact

You can advance the care, treatment and cure for Duchenne muscular dystrophy. Contributions in any amount can truly make a difference and can be credited to a fundraiser or event from the list below.